SHAREHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2016

Stockholders Equity Note [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

A summary of the Company's options activity (for employees and directors) under the 2010 Plan is as follows:

	Year ended December 31,
	2016				2015
			Weighted				Weighted
			average				average
	Number of		exercise		Number of		exercise
	options		price		options		price
Outstanding at beginning of year		1,824,369	$	5.83		1,540,869	$	7.30
Granted		1,015,571	$	4.60		445,000	$	5.70
Exercised		(1,875)	$	3.29		(4,000)	$	3.29
Cancelled *)		-	$	-		(112,500)	$	23.85
Forfeited		(90,125)	$	7.75		(45,000)	$	10.39
Outstanding at end of year		2,747,940	$	5.31		1,824,369	$	5.83
Vested and expected to vest		2,747,940	$	5.31		1,824,369	$	5.83
Options exercisable at the end of the year		1,200,823	$	6.17		843,661	$	6.50

*)  On March 31, 2015 the Company granted to its Chief Executive Officer ("CEO") options to purchase 400,000 of the Company's ordinary shares. On the same date, the Company cancelled 112,500 of the CEO's out-of-money options. The Company accounted for the cancellation of options, accompanied by the concurrent grant of options in accordance with ASC 718-20-35-8, "Cancellation and Replacement," and calculated the incremental compensation cost as the excess of the fair value of the replacement award over the fair value of the cancelled award at the cancellation date.

Schedule of Share-based Compensation, Activity [Table Text Block]

The options outstanding as of December 31, 2016, have been separated into ranges of exercise price, as follows:

	Outstanding						Exercisable
Exercise price	Number of options		Weighted average remaining contractual life (years)		Weighted average exercise price		Number of options		Weighted average remaining contractual life (years)		Weighted average exercise price
$					$						$
0.33-3.29		887,805		3.31		2.15		589,132		3.49		1.58
4.15-4.55		929,570		4.28		4.55		-		-		-
5.53-8.00		716,494		4.39		6.40		410,557		4.86		6.92
12.99-18.49		171,571		7.00		16.69		160,196		6.98		16.62
23.00-23.48		42,500		3.61		23.75		40,938		3.47		23.78
0.33-23.48		2,747,940		4.16		5.31		1,200,823		4.42		6.17

Schedule of Other Share-based Compensation, Activity [Table Text Block]

The outstanding options granted to the Company's consultants are as follows:

	Number of			Exercise
Grant date	options			price		Expiration date
February 28, 2010		8,805		$	2.184	February 28, 2020
February 17, 2011		3,804		$	0.0005	February 17, 2021
		12,609	*)

*) All options were fully vested on grant date.

Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]

The share-based expense recognized in the consolidated financial statements for services received from employees and directors is shown in the following table:

	Year ended
	December 31,
	2016		2015		2014
Research and development expenses	$	707	$	768	$	1,773
Pre-commercialization expenses		390		308		616
General and administrative expenses		1,403		1,289		1,700
	$	2,500	$	2,365	$	4,089